✦ LIBER ✦

Uricase and other novel agents for the management of patients with treatment-failure gout

✍ Scribed by John S. Sundy; Michael S. Hershfield

Book ID: 107553923
Publisher: Springer
Year: 2007
Tongue: English
Weight: 162 KB
Volume: 9
Category: Article
ISSN: 1523-3774
DOI: 10.1007/s11926-007-0041-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of Heart Failure (Greenberg/M

Management of Heart Failure (Greenberg/Management of Heart Failure) || Neurohormonal Blocking Agents in the Treatment of Patients with Left Ventricular Dysfunction and Heart Failure

✍ Greenberg, Barry H.; Barnard, Denise D.; Narayan, Sanjiv M.; Teerlink, John R. 📂 Article 📅 2010 🏛 John Wiley & Sons, Ltd 🌐 English ⚖ 792 KB

Reduction of plasma urate levels followi

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol–conjugated uricase) in patients with treatment-failure gout: Results of a phase II randomized study

✍ John S. Sundy; Michael A. Becker; Herbert S. B. Baraf; Andre Barkhuizen; Larry W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 1 views

Use of Novel and Conventional Biomarkers

Use of Novel and Conventional Biomarkers for Management of Patients With Heart Failure

✍ Kelly H. Schlendorf; Edward K. Kasper 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 225 KB

Levosimendan: A promising agent for the

Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure

✍ Lasse Lehtonen 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 458 KB

Levosimendan: A calcium-sensitizing agen

Levosimendan: A calcium-sensitizing agent for the treatment of patients with decompensated heart failure

✍ Lasse Lehtonen 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 491 KB

Is folate a promising agent in the preve

Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?

✍ De Vriese, An S. (author);Verbeke, Francis (author);Schrijvers, Bieke F. (author 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Management of the conventional cardiovascular risk factors is insufficient to prevent the dramatic increase in atherosclerotic cardiovascular morbidity and mortality in patients with renal failure. Folate recently received attention as a potential alternative treatment option to decrease the excess